Russia's Sputnik V vaccine 91.6% effective in late-stage trial - CNBC

1. Russia's Sputnik V vaccine 91.6% effective in late-stage trial  CNBC
2. Russia's Sputnik V vaccine is 91.6% effective against symptomatic Covid-19, interim trial results suggest  CNN
3. Russia's Sputnik V vaccine has 92% efficacy in trial  BBC News
4. Live updates: Russian vaccine more than 91% effective against coronavirus, peer-reviewed test results show  The Washington Post
5. Russian Covid-19 Vaccine Was Highly Effective in Trial, Boosting Moscow’s Rollout Ambitions  The Wall Street Journal
6. View Full Coverage on Google News

from World - Latest - Google News https://ift.tt/3tn8pAA
via IFTTT

• Tweet
• Share
• Share
• Share
• Share